The study for the efficacy of the combine therapy with proton pump inhibitor and irsogladine for the post-endoscopic submucosal dissection (ESD) gastric ulcer
Not Applicable
- Conditions
- Gastric ulcer
- Registration Number
- JPRN-UMIN000008161
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with repeated bleeding 2)major organ failure (such as cardiac and pulmonary complications) 3)Those with drug allergy 4)Concomitant administration of anticoagulants and antiinflammatory drugs 5)Patients with residual cancer histologically
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure rates of gastric ulcer at 4 and 8 weeks of the treatment
- Secondary Outcome Measures
Name Time Method